Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 5, 2004
[Autoreactive urticaria and autoimmune urticaria]M Maurer, M Metz, M Magerl, et al.HNO|May 10, 2012
[Urticaria. Basic knowledge for the ENT specialist]V Daut, P Staubach, K Hörmann, et al.Klinische Padiatrie|March 1, 2006
[Anaphylaxis after vaccination due to hypersensitivity to gelatin]W Kamin, P Staubach, B Klär-Hlawatsch, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 11, 2016
Controversies and challenges in the management of chronic urticariaP Staubach, T Zuberbier, C Vestergaard, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 25, 2007
[Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins]P Staubach-Renz, E von Stebut, W Bräuninger, et al.Allergy|April 3, 2016
The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important differenceK Weller, M Magerl, A Peveling-Oberhag, et al.The British Journal of Dermatology|January 17, 2012
Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1) -antihistamine dose escalationM Magerl, D Pisarevskaja, P Staubach, et al.Allergy|May 1, 2008
How to assess disease activity in patients with chronic urticaria?A Młynek, A Zalewska-Janowska, P Martus, et al.Allergy|March 25, 2016
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trialP Staubach, M Metz, N Chapman-Rothe, et al.Allergy|October 24, 2017
Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study dataP Staubach, M Metz, N Chapman-Rothe, et al.Pageof 6